Taproot has announced an initial five Cornerstone Centers, including three NCI-designated Cancer Centers, that have agreed to work together to provide a high volume of regulatory-grade data to advance precision oncology care.
The company says its test is the first capture-based myeloid genomic test to receive a CE-IVD mark
DNAnexus said the funding will support continued expansion in clinical trials and deployment of its Translational Informatics Suite
The partners will integrate Seqster's health data management platform with Scripps Research Translational Institute (SRTI)’s MyGeneRank app.
The world’s first processor expressly designed to perform secondary analysis of next-generation sequencing data is relieving the bottleneck between sequencing and practical application. Setting...
Already a leader among U.S. health systems in using genomics to guide care, the strategic alliance between NorthShore and Sema4 will significantly expand NorthShore’s existing clinical genomics offerings to more than 1,000 physicians and approximately 300,000 NorthShore patients.
New partnership comes two months after CancerLinQ and ONS launch CancerLinQ Ambassadors Program, a national practice engagement initiative.
In the new approach, patients are provided an additional informed consent document regarding sharing their information that research participants can choose to sign. This additional, or special consent, is additive to the standard informed consent papers required for participating in a research project.
AstraZeneca and The University of Manchester today said they would partner to deliver personalized healthcare for cancer patients through the use of clinical bioinformatics. Under...
For the first time, a deep-learning approach has been used to predict disease-associated metal-relevant site mutations in metalloproteins, providing a new platform to tackle human diseases.